Back
Ocuphire Pharma Quote, Financials, Valuation and Earnings
Sponsored
OCUP
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
OCUP
Ocuphire Pharma
Last Price:
1.35
Seasonality Move:
-20.18%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmOcuphire Pharma Price Quote
$1.35
+0.04 (+3.05%)
(Updated: September 18, 2024 at 6:55 PM ET)
Ocuphire Pharma Key Stats
Sell
33
Ocuphire Pharma (OCUP)
is a Sell
Day range:
$1.30 - $1.35
52-week range:
$1.15 - $4.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.91
P/B ratio:
0.84%
Volume:
76.8K
Avg. volume:
154.3K
1-year change:
-67.33%
Market cap:
$34.3M
Revenue:
$19M
EPS:
$-0.55
How Much Does Ocuphire Pharma Make?
-
How Much Are Ocuphire Pharma's Sales Annually?
OCUP Revenues are $19M -
How Much Profit Does Ocuphire Pharma's Make A Year?
OCUP net income is -$10M
Is Ocuphire Pharma Growing As A Company?
-
What Is Ocuphire Pharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.7% -
What Is Ocuphire Pharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Ocuphire Pharma Stock Price Performance
-
Did Ocuphire Pharma Stock Go Up Last Month?
Ocuphire Pharma share price went down by -1.5% last month -
Did OCUP's Share Price Rise Over The Last Year?
OCUP share price fell by -67.33% over the past 1 year
What Is Ocuphire Pharma 52-Week High & Low?
-
What Is Ocuphire Pharma’s 52-Week High Share Price?
Ocuphire Pharma has traded as high as $4.50 over the past 52 weeks -
What Is Ocuphire Pharma’s 52-Week Low Share Price?
Ocuphire Pharma has traded as low as $1.15 over the past 52 weeks
Ocuphire Pharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Ocuphire Pharma?
-
How Much Debt Does Ocuphire Pharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Ocuphire Pharma Have?
Cash and short term investments quarterly total is $41.4M -
What Is Ocuphire Pharma’s Book Value Per Share?
Book value per share is 1.56
Is Ocuphire Pharma Cash Flow Positive?
-
What Is OCUP Cash Flow From Operations?
Cash flow from operations (TTM) is -$11.5M -
What Is Ocuphire Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $12.9M -
What Is Ocuphire Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Ocuphire Pharma Return On Invested Capital
-
Is Management Doing A Good Job?
OCUP return on invested capital is -31.4% -
What Is Ocuphire Pharma Return On Assets?
ROA measures how assets are converting to revenues and is -28.41% -
What Is OCUP Return On Equity?
ROE is a measure of profitability and is -31.4%
Ocuphire Pharma Earnings Date & Stock Price
-
What Is Ocuphire Pharma's Stock Price Today?
A single share of OCUP can be purchased today for 1.31 -
What Is Ocuphire Pharma’s Stock Symbol?
Ocuphire Pharma trades on the nasdaq under the ticker symbol: OCUP -
When Is Ocuphire Pharma’s Next Earnings Date?
The next quarterly earnings date for Ocuphire Pharma is scheduled on November 13, 2024 -
When Is OCUP's next ex-dividend date?
Ocuphire Pharma's next ex-dividend date is September 19, 2024 -
How To Buy Ocuphire Pharma Stock?
You can buy Ocuphire Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ocuphire Pharma Competitors
-
Who Are Ocuphire Pharma's Competitors?
Below is a list of companies who compete with Ocuphire Pharma or are related in some way:
Ocuphire Pharma Dividend Yield
-
What Is OCUP Dividend Yield?
Ocuphire Pharma’s dividend yield currently is 0% -
What Is Ocuphire Pharma’s Payout Ratio?
Ocuphire Pharma’s payout ratio is 0% -
When Did Ocuphire Pharma Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is Ocuphire Pharma’s Dividend Per Share?
Ocuphire Pharma pays a dividend of $0.00 per share
Ocuphire Pharma Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -5.26% |
Revenue: | -69.73% | -42.75% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 16.75 |
Upside from Last Price: | 1178.63% |